ライフサイエンスコーパス: radiographic

1 Immunosuppressive therapy improved the radiographic abnormalities and pulmonary function of pat

2 any studies that have attempted to correlate radiographic acromial characteristics with rotator cuff

3 cal attachment level, gingival bleeding, and radiographic alveolar crestal height (ACH).

4 Among the subset for radiographic analysis (n = 53), there were significant c

5 Radiographic analysis of unreacted Marcellus shale thin

6 ion (DR) and bone filling (BF) were used for radiographic analysis.

7 mine whether treatment results in measurable radiographic and biologic changes in estrogen receptor (

8 Purpose To evaluate chest radiographic and chest CT findings of EVALI in the pedia

9 y available biomarkers (predictors) with key radiographic and clinical features of OA (outcomes) in o

10 Radiographic and clinical progression-free survival were

11 Chest radiographic and CT abnormalities were predominately bil

12 The number of dental radiographic and dental CT examinations performed was es

13 Radiographic and histologic analyses were consistent wit

14 Radiographic and histologic assessments for pulp regener

15 iomolecular assays and repaired mandibles by radiographic and histological assays.

16 We report the clinical, radiographic and histological features of the 33rd repor

17 number of osteoclasts were measured through radiographic and immunohistochemical analysis, respectiv

18 Radiographic and laboratory abnormalities, such as lymph

19 Conclusion A risk model based on chest radiographic and laboratory findings obtained at admissi

20 to prolonged clinical benefit and a lasting radiographic and metabolic response.

21 of this study was to evaluate the clinical, radiographic and patient-centered results of enamel matr

22 ins, and legumes may be related to decreased radiographic and symptomatic disease progression.

23 ietary pattern was associated with increased radiographic and symptomatic KOA progression, while foll

24 y patterns was significantly associated with radiographic and symptomatic progression of KOA.

25 ere consistently associated with established radiographic and/or clinical features of OA.

26 y confirmed R/M ACC of any primary site with radiographic and/or symptomatic progression were eligibl

27 ds (INCS) significantly improved endoscopic, radiographic, and clinical endpoints and patient-reporte

28 9 phenotype characterized by minor clinical, radiographic, and histopathologic changes in the two sur

29 arth of studies that have compared clinical, radiographic, and immunological peri-implant parameters

30 ogistic regression including clinical, chest radiographic, and laboratory findings.

31 lasia is a rare disorder which has clinical, radiographic, and manometric findings that are often ind

32 uideline committee defined HP, and clinical, radiographic, and pathological features were described.

33 LDH), high Creactive protein (CRP) and chest radiographic appearance exceeding one-lung area were ass

34 Low albumin and chest radiographic appearance exceeding one-lung area were ris

35 Radiographic appearance was similar between groups.

36 anifestations of recurrence (symptomatic and radiographic) are considered.

37 ) had pleural plaques, and 1,353 (32.0%) had radiographic asbestosis.

38 outcomes, success of implant placement or on radiographic assessment of grafted sites following horiz

39 radiographs, measured by using the modified Radiographic Assessment of Lung Edema (mRALE) score.

40 Four studies provided radiographic assessment of the PhMT-b and demonstrated i

41 Radiographic assessment was performed using periapical X

42 retation of multiple aspects of clinical and radiographic assessment.

43 tumor response to targeted therapies before radiographic assessment.See related commentary by Zou an

44 l antibody, has previously shown efficacy in radiographic axial spondyloarthritis (also known as anky

45 ving signs and symptoms in patients with non-radiographic axial spondyloarthritis at weeks 16 and 52.

46 ial therapeutic option for patients with non-radiographic axial spondyloarthritis who had an inadequa

47 hout definite radiographic sacroiliitis (non-radiographic axial spondyloarthritis), objective signs o

48 ty of ixekizumab, an IL-17 inhibitor, in non-radiographic axial spondyloarthritis.

49 are investigating clinical, pathologic, and radiographic biomarkers to help predict POD24, thereby i

50 healing, rhBMP-2-treated sites showed better radiographic bone density, greater defect fill, and sign

51 Mean radiographic bone fill was 1.06 +/- 0.81 and 1.0 +/- 0.9

52 Linear measurements of alveolar bone (radiographic bone level [rBL]), assessed in CBCT images

53 significant difference between clinical and radiographic bone level for 0.25-, 1-, and 3-mm CBCT sec

54 ility, plaque index, and gingival index) and radiographic bone level measurements were recorded at di

55 Radiographic bone loss (BL) was examined using orthopant

56 of androgen receptor significantly increased radiographic bone loss and tissue levels of IL-1alpha (P

57 bleeding on probing, visual inspection, and radiographic bone loss.

58 gth (IC), distance from the implant shoulder radiographic bone-to-implant contact (DIB), pink estheti

59 e of gingival recession and the condition of radiographic buccal bone, as well as the relative contri

60 y superior to original images in identifying radiographic calculus (P > 0.05).

61 Heritability of the radiographic categories used to classify FHD severity wa

62 Temporal radiographic changes and viral clearance were explored u

63 's Rank-Order correlation suggested temporal radiographic changes as a valuable predictor for viral c

64 ient age, gender, buccal plate thickness, or radiographic changes in ridge dimensions.

65 Criteria in Solid Tumors (RECIST) 1.1, other radiographic changes in tumor size and anatomic extent,

66 ims to evaluate and compare the clinical and radiographic changes obtained through Bioactive Glass (B

67 of targeted therapy well before clinical and radiographic changes occur.

68 n with suspected pneumonia but without chest radiographic changes or clinical or laboratory findings

69 stigate the diagnostic value of the temporal radiographic changes, and the relationship to disease se

70 We compared clinical and radiographic characteristics between patients with and w

71 This research aimed to compared chest radiographic characteristics of multidrug-resistant tube

72 Associations of clinical or radiographic characteristics with progression-free survi

73 s of acromial morphology and their different radiographic characteristics.

74 ssess the level of concordance between chest radiographic classifications of A and B Readers in a nat

75 Biochemical, radiographic, clinical antitumor response, and adverse e

76 -based severity score automatically measures radiographic COVID-19 pulmonary disease severity, which

77 Surgical management of IPMN based on radiographic criteria is variable between institutions,

78 CLD defined using clinical, spirometric, or radiographic criteria.

79 BASE, PubMed, and Cochrane to identify chest radiographic, CT, or US studies in adult patients suspec

80 ease progression in patients without obvious radiographic damage to the joint.

81 ls were higher, long-term IgM positivity and radiographic damage were more frequent.

82 Clinical and radiographic data on these patients were obtained from t

83 the aim of this study is to use clinical and radiographic data to test this association and determine

84 Demographic, clinical, laboratory, and radiographic data were analyzed.

85 tients, utilizing clinical, pathological and radiographic data.

86 nt level [CAL], gingival recession [GR]) and radiographic (defect Bone level [(DBL)] parameters for t

87 ent of the PhMT-b and demonstrated increased radiographic density or thicker facial bone after the tr

88 mel discoloration/cavitation but no clinical/radiographic dentin involvement, 12% (95% CI, 6%-22%) of

89 al enhancements do not significantly improve radiographic detection of dental calculus.

90 No radiographic differences were observed among groups at a

91 n = 53), there were significant clinical and radiographic dimensional changes in alveolar ridge width

92 PRISm is associated with increased symptoms, radiographic emphysema and gas trapping, exacerbations,

93 living with well-controlled HIV and minimal radiographic emphysema, HIV infection contributes to pul

94 58 (62%), respectively, reached the primary radiographic end point (risk difference, 4.7% [1-sided 9

95 Guideline-specific radiographic/endoscopic features were recorded.

96 aimed to examine the clinical utility of the radiographic evaluation of the bicipital groove in predi

97 Radiographic evaluation of the bicipital groove showed a

98 Before surgery, a radiographic evaluation was performed with a supine and

99 ophilia, sinusitis, and pulmonary nodules on radiographic evaluation.

100 from radiographic recurrence (that is, with radiographic evidence of a new stone, stone growth or st

101 ermined to what extent clinical relapses and radiographic evidence of disease activity contribute to

102 s among groups, and all subjects had minimal radiographic evidence of emphysema.

103 tes distributed over >=2 anterior teeth with radiographic evidence of horizontal bone loss.

104 5% CI: 83%, 98%) in studies of patients with radiographic evidence of isolated GT fracture (moderate

105 ions with clinical symptoms of OA as well as radiographic evidence of joint damage.

106 ptomatic joint pain patients present without radiographic evidence of joint destruction.

107 In patients with radiographic evidence of metastases and minimal symptoms

108 h hip or groin pain, the affected hip showed radiographic evidence of OA in 34% of cases.

109 teoarthritis Index score of at least 39, and radiographic evidence of OA of the knee were recruited f

110 nts and 1324 hips, of which 509 (38%) showed radiographic evidence of OA.

111 gnosis of OA in symptomatic patients without radiographic evidence of OA.

112 ty in IS specimens was associated with chest radiographic evidence of pneumonia (radiographic pneumon

113 inadequate response to OA analgesics, and no radiographic evidence of prespecified joint safety condi

114 creatinine 8.8-35.4 mumol/L (0.1-0.4 mg/dL); radiographic evidence of rickets (at least five particip

115 symptomatic stone (54%), at 5 years, 51% had radiographic evidence of stone passage (accompanied by s

116 ic stones, 49% accept if there is no current radiographic evidence of stones and urine profile is low

117 pected to have hip fracture but there was no radiographic evidence of surgical hip fracture (includin

118 on of ctDNA after chemoradiotherapy preceded radiographic evidence of tumor progression by an average

119 n recalled (>=1 y after T1) for clinical and radiographic examination (T2).

120 graphic records were preserved, we undertook radiographic examination of the skeletons of Dolly and h

121 eline and 12 months, a complete clinical and radiographic examination was done.

122 By radiographic examination, the mean thicknesses of sinus

123 Three hundred seventy-six in-hospital chest radiographic examinations for 366 individual patients we

124 Of the 376 chest radiographic examinations, 37 (10%) exhibited the charac

125 The percentage of BD-IPMN with >=1 high-risk radiographic feature differed between centers (MSK 69%,

126 Radiographic features from HRCT scans included ground-gl

127 the rate of BD-IPMN resected with high-risk radiographic features increased; however, the rate of hi

128 ectly trained model highlighted conventional radiographic features of CHF as reasons for an elevated

129 el is a feasible approach to reliably assess radiographic features of hip osteoarthritis.

130 es of this disease, we analyzed clinical and radiographic features of patients with SFR meningoenceph

131 cific data, with regard to which clinical or radiographic features predict non-benign histology, or c

132 In MD-IPMN cohort, the presence of radiographic features such as solid component and main p

133 Radiographic features were analyzed using cone-beam comp

134 in 1st-, 2nd-, 3rd-, 4th-, 6th-, or 8th-year radiographic findings compared with baseline).

135 Clinical parameters and radiographic findings from periapical radiographs and Co

136 Chest radiographic findings included ground-glass opacity in 1

137 rt stature, facial dysmorphism, and aberrant radiographic findings of the spine and long bone metaphy

138 The radiographic findings that correlated with MDR-TB were i

139 Purpose To determine the value of chest radiographic findings together with patient history and

140 Serum levels of sIL-2R and ACE and chest radiographic findings were assessed.

141 medications, recorded symptoms, vital signs, radiographic findings, and laboratory values.

142 with MSMp, nor were there any differences in radiographic findings, hospitalization rates, viral coin

143 ssions and, in admitted adults without focal radiographic findings, reduced antibiotic initiation.

144 bilateral infiltrates, but 33% had no acute radiographic findings.

145 sectional to obtain the relationship between radiographic findings.

146 es, nodules and tree-in-bud were significant radiographic findings.

147 detection in CSF, clinical presentation, and radiographic findings.

148 43%) in studies of patients with no definite radiographic fracture and 92% (134 of 157 patients; 95%

149 than no stimulation or placebo in promoting radiographic fusion in patients undergoing spinal fusion

150 d with hypophosphatasia, evaluated using the Radiographic Global Impression of Change (RGI-C) scale (

151 oup had significantly greater improvement in Radiographic Global Impression of Change global score th

152 rickets severity at week 40, assessed by the Radiographic Global Impression of Change global score.

153 The Radiographic Global Impression of Change score also indi

154 kets Severity Score and an adaptation of the Radiographic Global Impression of Change), and recumbent

155 038 pedigree-registered Maine Coon cats in a radiographic health screening programme for FHD to deter

156 ing the modified Fisher scale (grades: 0, no radiographic hemorrhage; 1, thin [< 1 mm in depth] subar

157 a multitask deep learning model for grading radiographic hip osteoarthritis features on radiographs

158 valuated tissues generated in bioreactors by radiographic, histological, mechanical, and biomolecular

159 g (RACD) (Group B) in function of a panel of radiographic, histomorphometric, and implant-related out

160 nt stem cell (iPSC)-lines from patients with radiographic hOA.

161 proportion with ILD events (endpoint met or radiographic ILA progression) was calculated.Measurement

162 A chest radiographic image suggested cardiomegaly and a computed

163 radiograph dataset comprising 112 120 chest radiographic images from 30 805 patients.

164 Estimations using static, free bending radiographic images gave measurement errors of up to 4 m

165 Radiographic images showed normal molars but abnormal ma

166 This review will outline the molecular and radiographic imaging appearance of benign and malignant

167 determined by independent central review of radiographic imaging every 16 weeks.

168 urrently depends on the presence of pain and radiographic imaging findings, which generally do not pr

169 Their potential for bi-modal radiographic imaging has never been fully realized, due

170 A median lead time over radiographic imaging of 96 days was observed.

171 We apply them for bi-modal radiographic imaging of biological and technological obj

172 ng a common lifting act, using novel dynamic radiographic imaging of the lumbar vertebral body motion

173 nents is lower than analytic estimations and radiographic imaging shows no visible artifacts, implyin

174 vic and rectovaginal examination, as well as radiographic imaging studies, were consistent with an In

175 Radiographic imaging with x-rays and protons is an omnip

176 owed up within 2 weeks, despite clinical and radiographic improvement in all, many had residual abnor

177 between statin use and longitudinal knee OA radiographic incidence, JSN progression, or nonacceptabl

178 We identified serologic and radiographic indicators of pMR that could help inform th

179 Clinical records and radiographic information were examined.

180 ients diagnosed with peri-implantitis with a radiographic infrabony defect were randomized into two g

181 tion of the condyle coupled with appropriate radiographic interpretation would thus be critical for t

182 ecommendations compared with two-dimensional radiographic interpretation?

183 e cohort, statin use had no association with radiographic JSN progression (HR, 1.37; [95% CI: 0.74, 2

184 Radiographic JSN progression was evaluated by using Oste

185 t replacement using 3D metrics combined with radiographic Kellgren & Lawrence grade (AUC 0.86) over t

186 Meaningful interpretation of changes in radiographic kidney stone burden requires understanding

187 the effect of statin use on the incidence of radiographic knee OA (development of Kellgren-Lawrence g

188 rker proteins could support the diagnosis of radiographic knee OA.

189 s were aged 40 to 85 years with symptomatic, radiographic knee osteoarthritis and Kellgren-Lawrence g

190 atin use was associated with reduced risk of radiographic knee osteoarthritis joint space narrowing p

191 Among participants with symptomatic radiographic knee osteoarthritis, the intra-articular ad

192 Radiographic KOA progression was assessed using 2 separa

193 The primary outcome measure was 3-y radiographic lesion progression.

194 versus -1.04 +/- 0.89; test versus control), radiographic linear bone gain (1.27 +/- 1.14 versus 1.08

195 atistically significant differences found in radiographic linear bone gain or clinical outcomes with

196 MR lymphangiography was calculated by using radiographic lymphangiography as the reference standard.

197 animals sustaining RCCL injury prior to the radiographic manifestation of OA, indicating that lubric

198 f bleeding and/or SUP on gentle probing, and radiographic marginal bone loss (MBL) >=3 mm.

199 ality after SAH, independent of clinical and radiographic markers.

200 otypes for any clinical parameter or for the radiographic MBL.

201 osa achieved similar clinical parameters and radiographic MBLs as those in thick tissue.

202 The radiographic mean marginal bone loss was 1.52 +/- 1.33 m

203 Radiographic (mean 6 +/- 5 days) and virologic recovery

204 No correlation was found between the radiographic measurements and LHBT pathology.

205 The radiographic measurements and the presence of LHBT patho

206 ex, liver disease diagnosis, MELD, AFP, NLR, radiographic Milan status, and number of LRT treatments

207 ts show that there is no correlation between radiographic morphologic evaluation of the bicipital gro

208 sociated with radicular/neuropathic pain and radiographic nerve root compression.

209 rations were correlated with the presence of radiographic OA and were elevated in three animals susta

210 We report a prevalence and distribution of radiographic-OA similar to that observed in naturally co

211 icance of baseline CTC AR-V7 on the basis of radiographic or clinical progression free-survival (PFS)

212 specific antigen (PSA) progression, standard radiographic or clinical progression, or at 2 years with

213 Radiographic osteoarthritis (OA) is most prevalent in th

214 mass index, physical activity, symptoms, and radiographic osteoarthritis features (Kellgren and Lawre

215 0.005; adjusted for covariates) but not with radiographic osteoarthritis.

216 s is the prediction of poor outcome, notably radiographic outcome in patients with psoriatic arthriti

217 ution of statins to knee osteoarthritis (OA) radiographic outcomes and the characteristics of patient

218 orting differences in clinical, esthetic, or radiographic outcomes of interest between sites underwen

219 human clinical trials reporting clinical and radiographic outcomes of patients receiving orthodontic

220 reated defects exhibited better clinical and radiographic outcomes suggestive of enhanced periodontal

221 ion of rotator cuff tears with commonly used radiographic parameters of acromial morphology and their

222 Clinical and radiographic parameters significantly improved 12 months

223 suppuration (P = 0.6), all the clinical and radiographic parameters were significantly increased whe

224 scuss the relevant diagnostic, clinical, and radiographic parameters, including probing depth, bleedi

225 th measurable disease at baseline achieved a radiographic partial response; and of 27 patients with i

226 percussion sensitivity, pulp vitality tests, radiographic pathology, and root-crown-ratio were all re

227 tifying COVID-19 with a characteristic chest radiographic pattern was 15.5% (31/200) and 96.6% (170/1

228 t is potentially a viable method to identify radiographic patterns that precede the development of IL

229 The median radiographic PCI was 25.

230 This study aimed to compare clinical and radiographic peri-implant parameters and levels of matri

231 d density in IS specimens from children with radiographic pneumonia and children with suspected pneum

232 more frequently in the IS specimens from the radiographic pneumonia compared with the nonpneumonia ca

233 The prevalence of radiographic pneumonia in North American studies was 19%

234 th chest radiographic evidence of pneumonia (radiographic pneumonia), we compared prevalence and dens

235 Radiographic presence of calculus was determined by two

236 cohort, we abstracted clinical demographic, radiographic, procedural, cytopathologic, and surgical d

237 8-CRP remission (DAS28-CRP <2.6) and with no radiographic progression (no increase in total van der H

238 ar cells (PBMCs) as models to predict future radiographic progression in OA patients enrolled in the

239 Radiographic progression was recorded in 4 of 29 infiltr

240 patients alive without events (AWE)-namely, radiographic progression, pain progression, chemotherapy

241 nts achieving an objective response, time to radiographic progression, safety, time to deterioration

242 nts perceived to be deriving benefit despite radiographic progression, were randomly assigned to cont

243 RD study, cabazitaxel significantly improved radiographic progression-free survival and overall survi

244 nificant improvement in overall survival and radiographic progression-free survival compared with pla

245 he primary endpoints of overall survival and radiographic progression-free survival in patients with

246 Median radiographic progression-free survival was 6.0 mo for T-

247 ients was assessed by overall survival (OS), radiographic progression-free survival, and prostate-spe

248 The primary endpoint was radiographic progression-free survival; here, we present

249 d disease activity remission rates or reduce radiographic progression.

250 t uncommon and leads to an increased risk of radiographic progression.

251 alyzed from baseline OAI visits in 58 future radiographic progressors (joint space narrowing at 24 mo

252 PXS scores correlated with radiographic pulmonary disease severity scores assigned

253 mas (N = 50), low observer confidence in the radiographic readings was associated with less chance of

254 ry outcome prediction models on the basis of radiographic readings: KL grade and OA Research Society

255 As none of the original clinical or radiographic records were preserved, we undertook radiog

256 redicted any manifestation of symptomatic or radiographic recurrence (5-year rate, 67%; c-statistic,

257 t are suspected, symptomatic recurrence from radiographic recurrence (that is, with radiographic evid

258 inical care and 25% detected by self-report; radiographic recurrence manifested as a new stone in 35%

259 e (through chart review) or self-report, and radiographic recurrence of any new stone, stone growth,

260 dney stone burden requires understanding how radiographic recurrence relates to symptomatic recurrenc

261 (44%, 529 of 1184), those with an equivocal radiographic report (58%, 71 of 126), and those with a h

262 RFS significantly correlated with pCR and radiographic response at the time of surgery.

263 ng treated with (223)Ra, there is a need for radiographic response biomarkers to minimize disease pro

264 and doxorubicin) for 6 or 12 weeks based on radiographic response followed by surgery and further ch

265 a quantitative assessment of bone scans for radiographic response in patients with metastatic castra

266 Radiographic response was assessed at 6 weeks.

267 Radiographic response was favorable in 3 patients, where

268 Radiographic response was seen in 7 (32%) of 22 patients

269 Secondary end points included toxicity, radiographic response, quality of life (QOL), and plasma

270 Radiographic responses were assessed centrally per Respo

271 fibroblasts obtained from two patients with radiographic rhizarthrosis and non-erosive hOA by introd

272 erences between the 2 experimental groups in radiographic root development ( P > 0.05).

273 ive axial spondyloarthritis without definite radiographic sacroiliitis (non-radiographic axial spondy

274 Participants with low BMIs had the highest radiographic severity of disease, the longest time to sp

275 PXS scores were correlated with radiographic severity scores independently assigned by t

276 ression levels significantly correlated with radiographic sinus disease severity (r = 0.56; P < .001)

277 eficiency, antibiotic allergy, lower FEV(1), radiographic sinus disease severity, nasal polyposis, an

278 r group, 412 patients (69%) had demonstrated radiographic stability at the 5-year time point.

279 ctDNA analyses of patients with radiographic stable or nonmeasurable disease improved pr

280 .Methods: Consecutive patients with clinical-radiographic stage T1 to T3, N0 to N3, and M0 NSCLC who

281 otentially facilitated, in part, by improved radiographic staging and endovascular techniques, and al

282 The retrospective clinical and radiographic study was therefore performed to investigat

283 ess associations between serum magnesium and radiographic subarachnoid hemorrhage severity.

284 Patients who initially underwent radiographic surveillance were divided into those with <

285 ement was most significantly correlated with radiographic suspicion of pneumonia and less so with res

286 To train and test the system we used 37424 radiographic tissue samples corresponding to eight diffe

287 was generally tolerable and induced pCRs and radiographic tumor regressions in approximately one half

288 We excluded patients who did not have a radiographic tumour assessment at 6 months.

289 t status were assessed based on clinical and radiographic variables to determine the prevalence of pe

290 y of SUP based on demographic, clinical, and radiographic variables.

291 ion system after stratification for previous radiographic vertebral fracture, and treatment was maske

292 T-score between -2.5 and -4.0 if no previous radiographic vertebral fracture, or between -1.5 and -4.

293 ratio [HR], 0.64 [95% CI, 0.50 to 0.82]) and radiographic vertebral fractures (both moderate SOE), wh

294 continuation versus discontinuation reduced radiographic vertebral fractures (zoledronic acid; low S

295 outcomes for odanacatib versus placebo were: radiographic vertebral fractures 3.7% (251/6770) versus

296 outcomes for odanacatib versus placebo were: radiographic vertebral fractures 4.9% (341/6909) versus

297 mproved BMD and reduced the incidence of new radiographic vertebral fractures in 1 high-quality trial

298 Denosumab also reduces risk for radiographic vertebral fractures, based on 1 trial.

299 r a step or a gap of 1-2 mm inclusive on any radiographic view.

300 nostic in MPeM and should be assessed during radiographic workup and integrated into clinical decisio